Artificial Heart Lung Machine Market to Reach US$ 3.5 Billion by 2032, Says Persistence Market Research

Market Overview

The global Artificial Heart Lung Machine Market is projected to grow from US$2.2 billion in 2025 to US$3.5 billion by 2032, expanding at a CAGR of 6.9% during the forecast period. These machines, also known as cardiopulmonary bypass systems, play a pivotal role during open-heart surgeries by oxygenating and circulating blood when the heart and lungs are temporarily stopped. Rising cardiovascular disease prevalence, technological advancements, and the growing demand for minimally invasive procedures are primary factors fueling this expansion.

Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/3476

Among the various segments, oxygenators lead the market with a 26.35% share, owing to their critical role in maintaining oxygen supply during surgical procedures. On the application side, Coronary Artery Bypass Grafting (CABG) dominates with a 32.5% share, reflecting its high procedure volume globally. North America remains the leading geographical region, commanding 42.20% market share in 2025, driven by advanced healthcare infrastructure, high surgical volumes, and strong adoption of innovative medical technologies. Meanwhile, Asia Pacific is poised to be the fastest-growing market due to healthcare investments, a rising burden of cardiovascular diseases, and rapid expansion of surgical facilities in countries like India and China.

✦ Key Highlights from the Report

✦ Global Artificial Heart Lung Machine Market valued at US$2.2 Bn in 2025.
✦ Market projected to reach US$3.5 Bn by 2032 with 6.9% CAGR.
✦ North America leads with 42.20% share in 2025 due to advanced surgical infrastructure.
✦ Asia Pacific expected to be the fastest-growing region through 2032.
✦ Oxygenators dominate with 26.35% market share among components.
✦ CABG leads applications with 32.5% global market share.

Market Segmentation
By Component Type

The artificial heart lung machine market is segmented into Oxygenators, Pumps, Cannula, Monitoring Systems, Heat Exchanger Units, Blood Reservoirs, and Others. Among these, oxygenators dominate, capturing nearly 26.35% of the global share in 2025. Their vital role in oxygenating and removing carbon dioxide from the blood makes them indispensable during cardiopulmonary bypass procedures. Monitoring systems are emerging as the fastest-growing component, spurred by the increasing demand for real-time data, AI integration, and advanced sensors that ensure patient safety during complex surgeries.

By Application Type

Applications are divided into Coronary Artery Bypass Grafting (CABG), Heart Valve Surgeries, Heart Transplant, Lung Transplant, and Others. CABG accounts for the largest share at 32.5% in 2025 due to the global burden of coronary artery disease. More than one million CABG procedures are performed annually, requiring heart lung machines to sustain circulation. Lung transplant surgeries, however, are projected to grow at the fastest rate, supported by rising respiratory disease prevalence and advancements in transplant success rates.

By End-User Type

End users include Hospitals, Cardiac Centers, and Others. Hospitals dominate with a 70% share in 2025, attributed to their ability to handle high surgical volumes and leverage advanced infrastructure. Cardiac centers are the fastest-growing segment, supported by the rising establishment of specialized centers equipped with state-of-the-art technologies for minimally invasive and transplant surgeries.

Read More In Detail: https://www.persistencemarketresearch.com/market-research/artificial-heart-lung-machine-market.asp

Regional Insights
🇺🇸 North America

North America remains the dominant region with a 42.20% market share in 2025, primarily due to the U.S. With high cardiovascular disease prevalence, increasing CABG and valve procedures, and robust adoption of advanced automated systems, the region sustains strong growth. Patient safety concerns and stringent FDA regulations also encourage hospitals to adopt biocompatible and efficient systems. Favorable reimbursement policies further support market expansion.

🇪🇺 Europe

Europe follows closely, led by Germany, the U.K., and France. Germany contributes the largest share, driven by sales from major players such as Terumo and Getinge. Regulatory initiatives like the EU Medical Device Regulation (MDR) foster innovation and compliance. The U.K. sees growing adoption of minimally invasive surgical solutions, while France experiences rising demand for transplant-related equipment. Environmental and sustainable manufacturing regulations also enhance long-term industry prospects.

Asia Pacific

Asia Pacific is the fastest-growing market, expanding at a projected CAGR of 6.53% during 2025-2032. India's high cardiovascular disease burden (affecting more than 60 million adults), combined with government initiatives like Ayushman Bharat, fuels demand for cost-effective systems. China is witnessing hospital expansions and large-scale investments in fully automated systems, while Japan focuses on precision-driven equipment for transplant surgeries. Increased healthcare spending and digital procurement platforms further accelerate adoption in the region.

Market Dynamics

Market Drivers

The artificial heart lung machine market is primarily driven by the rising prevalence of cardiovascular and respiratory diseases, which account for over 17.9 million deaths annually worldwide (WHO data). Aging populations further contribute to the growing need for open-heart surgeries. In addition, technological advancements, including automated monitoring systems and biocompatible oxygenators, have enhanced surgical safety and patient outcomes. Increasing healthcare infrastructure investments, supportive government initiatives, and favorable reimbursement policies also fuel global adoption.

Market Restraints

Despite strong demand, high costs associated with heart lung machines remain a barrier, especially in emerging economies. Beyond initial purchase, ongoing expenses such as consumables, maintenance, and staff training further escalate costs. Another critical restraint is the shortage of skilled perfusionists. A 2022 survey highlighted a 30% shortage in Asia Pacific, restricting adoption of advanced systems that require specialized expertise. These challenges limit accessibility in resource-constrained settings.

Market Opportunities

The development of portable and compact systems presents significant opportunities, particularly for rural and emergency care settings. Portable ECMO solutions such as Hemovent GmbH's MOBYBOX enable deployment in field hospitals and emergency transport. Additionally, the rise of minimally invasive surgeries like TAVR is generating demand for advanced heart lung machines capable of real-time monitoring. Integration of IoT-based diagnostics by players like LivaNova also opens avenues for remote monitoring, predictive maintenance, and enhanced operational efficiency.

Do You Have Any Query Or Specific Requirement? Request Customization of Report: https://www.persistencemarketresearch.com/request-customization/3476

# Frequently Asked Questions (FAQs)

How Big is the Artificial Heart Lung Machine Market in 2025?
Who are the Key Players in the Global Artificial Heart Lung Machine Market?
What is the Projected Growth Rate of the Artificial Heart Lung Machine Market?
What is the Market Forecast for Artificial Heart Lung Machines by 2032?
Which Region is Estimated to Dominate the Industry through the Forecast Period?

Company Insights

• Medtronic
• Terumo Europe NV
• LivaNova, Inc.
• Getinge
• Braile Biomédica
• NIPRO
• Tianjin Welcome Medical Equipment Co., Ltd.
• ELITE LIFECARE
• Hemovent GmbH
• MERA (Senko Medical Instrument Mfg. Co., Ltd.)
• Technowood International Pte. Ltd.

Recent Developments:

July 2025: Medtronic launched the VitalFlow ECMO system in Europe after receiving CE Mark approval, strengthening its portfolio in intensive care solutions.

May 2024: Hemovent GmbH expanded commercial use of its MOBYBOX portable ECMO system, designed to fit into a backpack, revolutionizing mobility in emergency cardiopulmonary support.

Conclusion

The Artificial Heart Lung Machine Market is entering a transformative phase marked by innovation, rising healthcare investments, and increasing surgical demands. While North America remains the largest market due to its advanced infrastructure and high adoption of innovative technologies, Asia Pacific is rapidly emerging as the next growth hub. Though cost barriers and skilled workforce shortages pose challenges, the rise of portable systems, IoT-enabled monitoring, and minimally invasive procedures is set to unlock new opportunities. As cardiovascular and respiratory diseases continue to rise globally, artificial heart lung machines will remain indispensable, driving steady market growth through 2032 and beyond.

Related Reports:

https://www.persistencemarketresearch.com/market-research/balancing-equipment-market.asp
https://www.persistencemarketresearch.com/market-research/cleanroom-air-filter-market.asp
https://www.persistencemarketresearch.com/market-research/outdoor-warning-siren-market.asp
https://www.persistencemarketresearch.com/market-research/radio-shuttle-system-market.asp
https://www.persistencemarketresearch.com/market-research/industrial-screen-printing-market.asp

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web:
https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.